Although TSHZ2 showed the highest mutation frequencies for colorectal and ovarian cancer cell lines only one out of the four MSI prostate cancer cell lines was positive for the TSHZ2 mutation. This evidence concerns the gene TSHZ2 and ovarian carcinoma.